<i>N</i>-甲基-<i>D</i>-天冬氨酸受体显像剂研究进展

颜成龙; 周杏琴; 曹国宪; 颜成龙; 周杏琴; 曹国宪

doi:10.3760/cma.j.issn.1673-4114.2009.01.009

[1]

Watkins JC,Jane DE.The glutamate story.Br J Pharmacol,2006,147(Suppl 1):S100-S108.

[2]

林奕斌,赵同军,展永.N-甲基-D-天氡氨酸受体的分子结构与生理功能.生物学杂志,2007,24(1):1-4.

[3]

Bendel O,Meijer B,Hurd Y,et al.Cloning and expression of the human NMDA receptor subunit NR3B in the adult human hippocampus.Neurosci Lett,2005,377(1):31-36.

[4]

Waxham WN.Neurotransmitter receptors//Zigmond M J,Bloom FE,Landis SC,et al.Fundamental neuroscience.London:Academic press,1999:251.

[5]

Yang Y,Wang XB,Frerking M,et al.Spine expansion and stabilization associated with long-term potentiation.J Neurosci,2008,28(22):5740-5751.

[6]

Wessell RH,Ahmed SM,Menniti FS,et al.NR2B selective NMDA receptor antagonist CP-101,606 prevents levedopa-indueed motor response alterations in hemi-parkinsonian rats.Neuropharmacology,2004,47(2):184-194.

[7]

Lipton SA.The molecular basis of menmantine action in Alzheimer's disease and other neurologic disorders:low-afflnity,uneompetitive antagonism.Curt Alzheimor Res,2005,2(2):155-165.

[8]

Loftis JM,Janowsky A.The N-methyl-D-aspartate recepor subunit NR2B:localization,functional properties,regulation,and clinical implications.Pharmacol Ther,2003,97(1):55-85.

[9]

Hahn CG,Wang HY,Cho DS,et al.Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia.Nat Med,2006,12(7):824-828.

[10]

Narita M,Aoki T,Suzuki T.Moecular evidence for the involvement of NR2B subunit containing N-methyl-D-aspartate receptors in the development of morphine-induced place preference.Neuroscience,2000,101(3):601-606.

[11]

Yukewicz L,Weaver J,Bullock MR,et al.The effect of the selective NMDA receptor antagonist traxoprodil in the treatment of traumatic brain injury.J Neurotrauma,2005,22(12):1428-1443.

[12]

Wang CX,Shuaib A.NMDA/NR2B selective antagonists in the treatment of iachemie brain injury.Curt Drug Targets CNS Neurol Disord,2005,4(2):143-151.

[13]

Guo W,Wei F,Zou S,et al.Group I metabotropic gluatmate receptor NMDA receptor coupling and signaling cascade mediate spinal dorsal horn NMDA receptor 2B tyrnsine phosphorylation associated with inflammatory hyperalgesia.J Neurosci,2004,24(41):9161-9173.

[14]

Bajo M,Crawford EF,Roberto M,et al.Chronic morphine treatment alters expression of N-methyl-D-asparate receptor subunits in the extended amygdala.J Neurnsci Res,2006,83(4):532-537.

[15]

Owens J,Wyper DJ,Patterson J,et al.First SPET images of glutaroate(NMDA) receptor activation in vivo in cerebral ischacmia.Nucl Med Commun,1997,18(2):149-158.

[16]

Elfverson M,Linde AM,Le Greves P,et al.Neuresteroids allosterically modulate the ion pore of the NMDA receptor consisting of NR1/NR2B but not NR1/NR2A.Biochem Biophys Res Commun,2008,327(2):305-308.

[17]

Kiesewetter DO,Finn RD,Rice KC,et al.Synthesis of ¹¹C-labeled (+-)-5-methyl-10,11-dihydre-5H-dibenzo[a,d]cyclohepten-5,10-imin e[(+-)-[¹¹C]MK801].Int J Rad Appl Instrum[A],1990,41(2):139-142.

[18]

Samnick S,Ametamey SM,Leenders KL,et al.Electrophysiological study,biodistributian in mice,and preliminary PET evaluation in a rhesus monkey of 1-amino-3-[¹⁸F]fluoromethyl-5-methyladamantane (¹⁸F-MEM):a potential radioligand for mapping the NMDA-receptor complex.Nucl Med Biol,1998,25(4):323-330.

[19]

Ametamey SM,Samnick S,Leenders KL,et al.Fluorine-18 radiolabelling,biedistribution studies and preliminary PET evaluation of a new memantine derivative for imaging the NMDA receptor.J Recept Siqnal Transduct Res,1999,19(1-4):129-141.

[20]

Ametamey SM,Bruehlmeier M,Kneifel S,et al.PET studies of ¹⁸F-memantine in healthy volunteers.Nucl Med Biol,2002,29(2):227-231.

[21]

张建康,周杏琴,钦晓峰,等.放射性^99mTc标记的NMDA受体配基N₂S₂-Memantine的合成.化学试剂,2008,30(11):842-844.

[22]

Bressan RA,Erlandsson K,Stone JM,et al.Impact of achizophrenia and chronic antipsychotie treatment on[¹²³I]CNS-1261 binding to N-methyl-D-aspartate receptors in vivo.Biol Psychiatry,2005,58(1):41-46.

[23]

Stone JM,Erlandsson K,Arstad E,et al.Ketamine displaces the novel NMDA receptor SPET probe[¹²³I]CNS-1261 in humans in vivo.Nucl Med Biol,2006,33(2):239-243.

[24]

Stone JM,Erlandsson K,Arstad E,et al.Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy:a[¹²³I]CNS-1261 SPET study.Psychopharmacolngy (Berl),2008,197(3):401-408.

[25]

Waterhoase RN,Slifstein M,Dumont F,et al.In vivo evaluation of[¹¹C]N-(2-chloro-5-thiomethylpbenyl)-N'-(3-methoxy-phenyl)-N'-me-thylguanidine ([¹¹C]GMOM) as a potential PET radiotracer for the PCP/NMDA receptor.Nucl Med Biol,2004,31(7):939-948.

[26]

Haradahira T,Okauchi T,Maeda J,et al.Effects of endogenous agonists,glyeine and D-serine,on in vivo specific binding of[¹¹C]L-703,717,a PET radioligand for the glycine-binding site of NMDA receptors.Synapse,2003,50(2):130-136.

[27]

Matsumoto R,Haradahira T,Ito H,et al.Measurement of glycine binding site of N-methyl-D-asparate receptors in living human brain using 4-acetoxy derivative of L-703,717,4-acetoxy-7-chloro-3-[3-(4-[¹¹C]methoxybenzyl) phenyl]-2(IH)-quinolons (AcL703) with positron emission tomography.Synapse,2007,61(10):795-800.

[28]

Fuchiqami T,Haradahira T,Fujimoto N,et al.Difference in brain distributions of carbon 11-labeled 4-hydroxy-2(1H)-quinolones as PET radioligands for the glycine-binding site of the NMDA ion channel.Nucl Med Biol,2008,35(2):203-212.

[29]

Waterhonse RN,Sultana A,Laruelle M.In vivo evaluation of[¹¹C]3-[2[(3-methoxyphenylamino) carbonyl]ethenyl]-4,6-dichloroindole-2-caboxylic acid ([¹¹C]3MPICA) as a PET radiotracer for the glycine site of the NMDA ion channel.Nucl Med Biol,2002,29(8):791-794.